Literature DB >> 1350462

In utero treatment with monoclonal antibody to IL-2 receptor beta-chain completely abrogates development of Thy-1+ dendritic epidermal cells.

T Tanaka1, Y Takeuchi, T Shiohara, F Kitamura, Y Nagasaka, K Hamamura, H Yagita, M Miyasaka.   

Abstract

Interleukin-2 (IL-2), a crucial growth factor for mature T lymphocytes, is produced in fetal thymus under developmental control, although its biological significance remains unclear. We found that the two distinct subunits of the IL-2 receptor, i.e. the alpha-chain (IL-2R alpha) and the beta-chain (IL-2R beta), were expressed in an almost mutually exclusive fashion throughout fetal thymus ontogeny, and that the blockade of IL-2R beta, a signal transducing component of IL-2R, by administering a neutralizing mAb to IL-2R beta resulted in the complete and selective disappearance of Thy-1+ skin dendritic epidermal cells. Development of any other T cell subsets was uncompromised. This indicates that IL-2 plays a crucial role in the development of fetal V gamma 5+ cells and their descendants.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1350462     DOI: 10.1093/intimm/4.4.487

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  7 in total

1.  The immediate-early gene product Egr-1 regulates the human interleukin-2 receptor beta-chain promoter through noncanonical Egr and Sp1 binding sites.

Authors:  J X Lin; W J Leonard
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

2.  Blockade of T- and B-lymphocyte development by antibody to the gamma c subunit of the receptors for interleukins 2, 4, and 7.

Authors:  Y W He; R B Levy; T R Malek
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

3.  The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells.

Authors:  R N Bamford; A J Grant; J D Burton; C Peters; G Kurys; C K Goldman; J Brennan; E Roessler; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

4.  Differential effects of interleukin-15 and interleukin-2 on differentiation of bipotential T/natural killer progenitor cells.

Authors:  G Leclercq; V Debacker; M de Smedt; J Plum
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

5.  Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor beta chain.

Authors:  H Suzuki; G S Duncan; H Takimoto; T W Mak
Journal:  J Exp Med       Date:  1997-02-03       Impact factor: 14.307

6.  Impaired development of V gamma 3 dendritic epidermal T cells in p56lck protein tyrosine kinase-deficient and CD45 protein tyrosine phosphatase-deficient mice.

Authors:  K Kawai; K Kishihara; T J Molina; V A Wallace; T W Mak; P S Ohashi
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

7.  Selective long-term elimination of natural killer cells in vivo by an anti-interleukin 2 receptor beta chain monoclonal antibody in mice.

Authors:  T Tanaka; F Kitamura; Y Nagasaka; K Kuida; H Suwa; M Miyasaka
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.